
HOYA Q1 FY2027: sales, profit jump, ¥200 billion buyback announced
Revenue
¥255.7B
+16.0%
Operating Profit
¥82.6B
+30.0%
Net Income
¥65.8B
+26.9%
Operating Margin
32.3%
HOYA’s fiscal first quarter ended June 2026 showed revenue rising 16.0% to ¥255,742 million, with operating profit jumping 30.0% to ¥82,626 million. Net profit attributable to owners increased 26.9% to ¥65,791 million, driven by strong semiconductor-related demand and healthcare product sales. Simultaneously, the company announced a ¥200 billion share buyback.
Key Results
For the three months ended June 2026, HOYA posted revenue of ¥255,742 million, a 16.0% increase year on year. Operating profit surged 30.0% to ¥82,626 million, and net profit attributable to owners of the parent climbed 26.9% to ¥65,791 million. The operating margin expanded sharply to 32.3% from 28.8% a year earlier. Profit from ordinary activities, which reflects core business strength, rose 24.4% to ¥82,367 million, while pre-tax profit grew 27.7% to ¥85,994 million. Both the Life Care and Information & Communication segments contributed through high-value-added products.
HOYA did not disclose a full-year forecast, opting instead for a first-half outlook for the fiscal year ending March 2027. The company expects revenue of ¥521,000 million and operating profit of ¥165,000 million, well above the year-earlier first-half actuals of ¥454,899 million and ¥131,744 million, respectively.
Segment Performance
HOYA operates through two main segments: Life Care and Information & Communication (a third segment, Other, became negligible after the sale of a voice synthesis software business in October 2025).
Life Care revenue rose 12.8% to ¥154,788 million, with segment profit up 23.6% to ¥29,984 million, lifting the segment margin to 19.4%. Eyeglass lenses performed strongly in chain stores, and the high-value-added MiYOSMART lens for myopia management posted significant growth in Europe, China, and South America. Contact lens sales benefited from new store openings and robust demand for the private brand “hoyaONE.” In medical, premium intraocular lenses for cataract surgery expanded, while endoscope revenue increased in yen terms due to a weaker currency but declined on a local-currency basis amid ongoing restructuring.
Information & Communication revenue jumped 22.7% to ¥100,954 million, and segment profit climbed 27.8% to ¥55,615 million, yielding an exceptionally high margin of 55.1%. In electronics, semiconductor mask blanks saw a sharp revenue increase, driven by stronger demand for EUV-related advanced products and a richer high-end product mix. FPD photomasks expanded with the ramp-up of a new China plant, and HDD glass substrates for nearline data-center storage remained robust. The Optical Solutions division (formerly imaging) posted strong growth, with stable interchangeable lens sales for mirrorless cameras and higher volumes from CUPO and wearable camera lenses.
| Segment | Revenue | Share | Op. Profit | Op. Margin |
|---|---|---|---|---|
| Life Care | ¥154.8B | 61% | ¥30.0B | 19.4% |
| Information & Communication | ¥101.0B | 40% | ¥55.6B | 55.1% |
Financial Position and Capital Policy
At quarter-end, total assets stood at ¥1,301,827 million, roughly flat from the prior fiscal year-end. Equity attributable to owners of the parent slipped to ¥1,030,602 million, reflecting share buybacks and dividend payments, but the equity ratio remained high at 78.0%.
Operating cash flow expanded by ¥12,773 million year on year to ¥70,000 million. Investing cash flow was a net outflow of ¥7,106 million, while financing cash flow saw a net outflow of ¥88,241 million, mainly due to increased dividend payments (¥170 per share, totaling approximately ¥57,033 million) and share repurchases of ¥28,052 million. Cash and cash equivalents at period end were ¥555,494 million.
HOYA paid annual dividends of ¥295 per share in the previous fiscal year (interim ¥125 and year-end ¥170) but has not yet decided on dividends for the current year. The company sets dividends based on performance and investment plans, and will announce an interim dividend with second-quarter results.
On the day of the earnings release, the board resolved a ¥200 billion share buyback, authorizing the purchase of up to 10 million shares (2.99% of outstanding shares) between August 2026 and March 2027. All acquired shares will be canceled, aiming to enhance per-share value and improve return on equity.
Outlook
HOYA provides a full-year forecast only from the third quarter onward, citing high exposure to foreign exchange and the intermediate-goods nature of its Information & Communication business. For the first half (April–September 2026), the company projects sharp profit gains.
| FY3/26 H1 Actual | FY3/27 H1 Forecast | Change | |
|---|---|---|---|
| Revenue | ¥454,899 million | ¥521,000 million | +14.5% |
| Operating profit | ¥131,744 million | ¥165,000 million | +25.2% |
| Pre-tax profit | ¥139,294 million | ¥170,000 million | +22.0% |
| Net profit* | ¥107,268 million | ¥131,000 million | +22.1% |
| Basic EPS | ¥313.19 | ¥391.54 | +25.0% |
*Attributable to owners of the parent.
HOYA expects continued strength in eyeglass and contact lenses within Life Care, and sustained demand for semiconductor mask blanks and HDD substrates in Information & Communication. The outlook remains sensitive to currency moves and semiconductor cycle fluctuations.
Risks and Challenges
HOYA identifies several key risks:
- Currency volatility: A high proportion of overseas revenue means a stronger yen could pressure results, despite the current tailwind from yen weakness.
- Information & Communication cyclicality: Products such as semiconductor mask blanks and HDD glass substrates are intermediate goods, making them vulnerable to shifts in end-market demand and data center investment trends.
- Life Care restructuring: The medical endoscope business continues to contract in local-currency terms; the success of restructuring efforts is critical to a margin recovery.
- Competitive landscape: HOYA differentiates through high-value-added products, but technological advances by competitors and price competition remain ongoing risks.
Strategic Topic: ¥200 billion Share Buyback
The ¥200 billion buyback announced alongside earnings represents a continuation of large-scale shareholder returns from the prior year. With a ceiling of 10 million shares (about 3% of outstanding stock) and a buyback window from August 2026 to March 2027, all repurchased shares will be canceled. HOYA stated the move aims to “strengthen shareholder returns, improve capital efficiency, and enable agile capital policy.” The buyback underscores the company’s commitment to deploying its robust cash generation and healthy balance sheet to sustain proactive, large-scale capital returns.
Analyst take
HOYA’s quarter stood out for the Information & Communication segment’s exceptional 55%+ margin, driven by a high share in semiconductor mask blanks and HDD glass substrates. Life Care also delivered steady margin improvement. The ¥200 billion buyback, on top of strong cash generation, signals a confident, shareholder-friendly stance. The decision to delay full-year guidance reflects prudent caution on forex and chip cycles; sustainability in Information & Communication will be the key focus when a full-year view is given in the third quarter.
